Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

Annals of Oncology(2024)10.1016/j.annonc.2024.06.009Source: DataRank Database

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers is a research paper published in Annals of Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: hybridTopics (33)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (46)

Marco Bruzzone ORCID,R. Bas,Hyun Jin Kim ORCID,Antonio Di Meglio ORCID,Rinat Bernstein‐Molho ORCID

Live enrichment

PubMed:38908482

National Institutes of Health

Grant: 5R01CA159868-02

Genes, environment and breast cancer risk: The 15 year follow-up of the Prof-SC

National Health and Medical Research Council (NHMRC)

Grant: 454508

kConFab Follow-Up Project: A Prospective Study of Non-Genetic Risk Modifiers in Women at High Risk for Breast Cancer

National Health and Medical Research Council (NHMRC)

Grant: 288704

Risk factors, screening, prophylaxis and outcomes in individuals from breast cancer families: kConFab Follow-Up Study

National Institutes of Health

Grant: 5R35CA253187-06

Resolving the cancer relevance of predisposition gene mutations

National Institutes of Health

Grant: 5P50CA116201-08

Career Development (Ingle)

hybridLicense: CC BY NC ND

publisherhttps://api.elsevier.com/content/article/PII:S0923753424007403?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0923753424007403?httpAccept=text/plain

https://doi.org/10.1016/j.annonc.2024.06.009

https://pubmed.ncbi.nlm.nih.gov/38908482

https://hdl.handle.net/11351/11987

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

AdultMama - Càncer - PrognosiHeterozygoteOther subheadings::Other subheadings::Other subheadings::/genetics610Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesDisease-Free SurvivalYoung AdultBRCA; early breast cancer; hormone receptor status; tumor subtypes; young patientsFENÓMENOS Y PROCESOS::fenómenos genéticos::estructuras genéticas::genoma::componentes genómicos::genes::genes de neoplasias::genes supresores de tumores::genes BRCA1Otros calificadores::Otros calificadores::Otros calificadores::/genéticaBiomarkers, TumorHumansGerm-Line MutationRetrospective StudiesBRCA2 ProteinGens del càncerFENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutaciónBRCA1 ProteinPrognosisAnomalies cromosòmiquesPHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Genes, Neoplasm::Genes, Tumor Suppressor::Genes, BRCA1Receptors, EstrogenPHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::MutationMama - Càncer - Aspectes genèticsFemaleReceptors, ProgesteroneENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mamaDISEASES::Neoplasms::Neoplasms by Site::Breast NeoplasmsBRCA; early breast cancer; hormone receptor status; tumor subtypes; young patients;